Phase II trial of single-agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash Meeting Abstract
| Authors: | Schilder, R. J.; Lokshin, A. E.; Holloway, R. W.; Alvarez, R. D.; Pathak, H.; Aghajanian, C.; Drescher, C. W.; Godwin, A. K. |
| Abstract Title: | Phase II trial of single-agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash |
| Meeting Title: | 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 25 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2007 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2007-06-20 |
| Start Page: | 293s |
| Language: | English |
| ACCESSION: | WOS:000455043701357 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2007.25.18_suppl.5577 |
| Notes: | Meeting Abstract: 5577 -- Source: Wos |
